Finance

Lists
TENX:NASDAQ
Tenax Therapeutics Inc
၁.၈၇ US$
+၀.၅၄%
(+၀.၀၁၀၀) 1D
၁.၈၆ US$
-၀.၅၃% (-၀.၀၁၀၀)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TENX...
Open
၁.၈၆ US$
High
၁.၉၁ US$
Low
၁.၈၀ US$
Mkt. cap
၇.၀၀ ကုဋေ
Avg. vol.
၄.၀၄ သန်း
Volume
၂.၃၄ သန်း
52-wk high
၁၉.၄၀ US$
52-wk low
၁.၃၁ US$
EPS
-၁.၄၇ US$
Beta
၀.၉၂
Shares outstanding
၃.၇၄ ကုဋေ
No. of employees
၁၅
Open
၁.၈၆ US$
High
၁.၉၁ US$
Low
၁.၈၀ US$
Mkt. cap
၇.၀၀ ကုဋေ
Avg. vol.
၄.၀၄ သန်း
Volume
၂.၃၄ သန်း
52-wk high
၁၉.၄၀ US$
52-wk low
၁.၃၁ US$
EPS
-၁.၄၇ US$
Beta
၀.၉၂
Shares outstanding
၃.၇၄ ကုဋေ
No. of employees
၁၅
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Tenax pauses Phase 3 levosimendan trial to refine criteria
About Tenax Therapeutics Inc
CEOChris Giordano
Employees၁၅
Founded၁၉၆၇
Headquarters-
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to TENX in the past 3 months
Buy
Buy
6
Hold
4
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TENX in the last 3 months.
Highest
Current ၁.၈၇ US$
၃၅.၀၀ US$ (+၁,၇၇၁.၆၆%)
Average
၉.၆၃ US$ (+၄၁၄.၉၇%)
Lowest
၄.၀၀ US$ (+၁၁၃.၉၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၁၄.၀၀ US$
+၆၄၈.၇%
09/15/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
၃၅.၀၀ US$
+၁,၇၇၁.၇%
09/09/2026
Angela Qian
Canaccord Genuity
Buy
Maintained
၄.၀၀ US$
+၁၁၃.၉%
08/31/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/31/2026
Seamus Fernandez
Guggenheim
Hold
Downgraded
-
-
08/31/2026
Gautam Chukka
Chardan Capital
Hold
Downgraded
၅.၀၀ US$
+၁၆၇.၄%
08/11/2026
David Risinger
Leerink Partners
Buy
Maintained
၄.၀၀ US$
+၁၁၃.၉%
08/11/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
၅.၀၀ US$
+၁၆၇.၄%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Hold
Downgraded
၅.၀၀ US$
+၁၆၇.၄%
08/10/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
၅.၀၀ US$
+၁၆၇.၄%
08/10/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
၃၅.၀၀ US$
+၁,၇၇၁.၇%
07/28/2026
Unknown Analyst
Chardan Capital
Buy
Initiated
၂၇.၀၀ US$
+၁,၃၄၃.၉%
06/22/2026
Unknown Analyst
Roth MKM
Buy
Maintained
၃၀.၀၀ US$
+၁,၅၀၄.၃%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၀၃ ကုဋေ
၁.၀၅ ကုဋေ
၁.၁၅ ကုဋေ
၁.၂၈ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆.၄၈ သန်း
၅.၉၁ သန်း
၅.၀၃ သန်း
၅.၉၃ သန်း
Operating expense
၁.၆၈ ကုဋေ
၁.၆၄ ကုဋေ
၁.၆၆ ကုဋေ
၁.၈၈ ကုဋေ
Total operating expenses
၁.၆၈ ကုဋေ
၁.၆၄ ကုဋေ
၁.၆၆ ကုဋေ
၁.၈၈ ကုဋေ
Operating income
-၁.၆၈ ကုဋေ
-၁.၆၄ ကုဋေ
-၁.၆၆ ကုဋေ
-၁.၈၈ ကုဋေ
Other non operating income
-၁.၅၀ သောင်း
-၉.၀၀ ထောင်
-၄.၀၀ ထောင်
-
EBT including unusual items
-၁.၅၈ ကုဋေ
-၁.၅၅ ကုဋေ
-၁.၅၇ ကုဋေ
-၁.၇၈ ကုဋေ
EBT excluding unusual items
-၁.၅၈ ကုဋေ
-၁.၅၅ ကုဋေ
-၁.၅၇ ကုဋေ
-၁.၇၈ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၅၈ ကုဋေ
-၁.၅၅ ကုဋေ
-၁.၅၇ ကုဋေ
-၁.၇၈ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၀
-၀.၃၈
-၀.၃၅
-၀.၃၅
Interest and investment income
၁.၀၂ သန်း
၉.၁၈ သိန်း
၈.၆၁ သိန်း
၉.၈၁ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၀၂ သန်း
၉.၁၈ သိန်း
၈.၆၁ သိန်း
၉.၈၁ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ